Hamza, Abderaouf http://orcid.org/0000-0001-6977-4213
El-Sissy, Carine
Yousfi, Nadhir
Martins, Paula Vieira
Rafat, Cédric
Masliah-Planchon, Julien
Frémeaux-Bacchi, Véronique
Mesnard, Laurent http://orcid.org/0000-0002-0339-3757
Article History
Received: 27 September 2022
Revised: 14 March 2023
Accepted: 20 March 2023
First Online: 10 April 2023
Competing interests
: VF-B manages a genetic testing facility that uses MLPA in the diagnosis of aHUS. The other authors declare no competing interests.
: The study was performed in accordance with the ethical standards of the Declaration of Helsinki. Written informed consent was obtained regarding de-identified clinical and personal patient data collection, analysis and publication. The study has been approved by an Institutional Review Board (Direction de la Recherche Clinique et de l’Innovation (APHP220461)) and the Ethic board of Sorbonne Université (CER-2022-009).